We demonstrated that PBMCs isolated from patients with DM produced higher levels of Gal-9 compared to IMNM patients and HCs, suggesting that PBMCs are among the sources of serum Gal-9 in patients with DM. This evidence concerns the gene LGALS9 and dermatomyositis.